|
[1]
|
Voulgari, C., Papadogiannis, D. and Tentolouris, N. (2010) Diabetic Cardiomyopathy: From the Pathophysiology of the Cardiac Myocytes to Current Diagnosis and Management Strategies. Vascular Health and Risk Management, 6, 883-903. [Google Scholar] [CrossRef]
|
|
[2]
|
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., Stein, C., Basit, A., Chan, J.C.N., Mbanya, J.C., Pavkov, M.E., Ramachandaran, A., Wild, S.H., James, S., Herman, W.H., Zhang, P., Bommer, C., Kuo, S., Boyko, E.J. and Magliano, D.J. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article ID: 109119. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Bertoni, A.G., Hundley, W.G., Massing, M.W., Bonds, D.E., Burke, G.L. and Goff, D.C. (2004) Heart Failure Prevalence, Incidence, and Mortality in the Elderly with Diabetes. Dia-betes Care, 27, 699-703. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Leiner, T., Bogaert, J., Friedrich, M.G., Mohiaddin, R., Muthurangu, V., Myerson, S., et al. (2020) SCMR Position Paper (2020) on Clinical Indications for Cardiovascular Magnetic Reso-nance. Journal of Cardiovascular Magnetic Resonance, 22, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Vasquez, M. and Nagel, E. (2019) Clinical Indications for Car-diovascular Magnetic Resonance. Heart (British Cardiac Society), 105, 1755-1762. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Khan, S., Ahmad, S.S. and Kamal, M.A. (2021) Diabetic Car-diomyopathy: From Mechanism to Management in a Nutshell. Endocrine, Metabolic & Immune Disorders—Drug Tar-gets, 21, 268-281. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Mordi, I.R. (2019) Non-Invasive Imaging in Diabetic Cardiomyopathy. Journal of Cardiovascular Development and Disease, 6, Article No. 18. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Dean, J., Cruz, S.D., Mehta, P.K., et al. (2015) Coronary Microvascular Dysfunction: Sex-Specific Risk, Diagnosis, and Therapy. Nature Reviews Cardiology, 12, 406-414. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Jensen, M.T., Fung, K., Aung, N., Sanghvi, M.M., et al. (2019) Changes in Cardiac Morphology and Function in Individuals with Diabetes Mellitus: The UK Biobank Cardiovascular Magnetic Resonance Substudy. Circulation: Cardiovascular Imaging, 12, e009476. [Google Scholar] [CrossRef]
|
|
[10]
|
Gao, Y., Yang, Z., Ren, Y., et al. (2019) Evaluation of Myocardial Fibrosis in Diabetes with Cardiac Magnetic Resonance T1-Mapping: Correlation with the High-Level Hemo-globin A1c. Diabetes Research and Clinical Practice, 150, 72-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Patscheider, H., Lorbeer, R., Auweter, S., et al. (2018) Subclin-ical Changes in MRI-Determined Right Ventricular Volumes and Function in Subjects with Prediabetes and Diabetes. European Radiology, 28, 3105-3113. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Shenoy, C., Romano, S., Hughes, A., et al. (2020) Cardiac Mag-netic Resonance Feature Tracking Global Longitudinal Strain and Prognosis after Heart Transplantation. JACC: Cardio-vascular Imaging, 13, 1934-1942. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Maceira, A.M., Guardiola, S., Ripoll, C., Cosin-Sales, J., Belloch, V. and Salazar, J. (2020) Detection of Subclinical Myocardial Dysfunction in Cocaine Addicts with Feature Tracking Cardiovascular Magnetic Resonance. Journal of Cardiovascular Magnetic Resonance, 22, 70. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Morris, D.A., Otani, K., Bekfani, T., Takigiku, K., Izumi, C., Yuda, S., et al. (2014) Multidirectional Global Left Ventricular Systolic Function in Normal Subjects and Patients with Hypertension: Multicenter Evaluation. Journal of the American Society of Echocardiography, 27, 493-500. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Halliday, B.P., Senior, R. and Pennell, D.J. (2021) Assessing Left Ventricular Systolic Function: From Ejection Fraction to Strain Analysis. European Heart Journal, 42, 789-797. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Jiang, L., Wang, J., Liu, X., et al. (2020) The Combined Effects of Cardiac Geometry, Microcirculation, and Tissue Characteristics on Cardiac Systolic and Diastolic Function in Subclinical Diabetes Mellitus-Related Cardiomyopathy. International Journal of Cardiology, 320, 112-118. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Xie, L.J., Dong, Z.H., Yang, Z.G., Deng, M.Y., Gao, Y., Jiang, L., Hu, B.Y., Liu, X., Ren, Y., Xia, C.C., Li, Z.L., Zhang, H.P., Zhou, X.Y. and Guo, Y.K. (2020) Assessment of Left Ventricular Deformation in Patients with Type 2 Diabetes Mellitus by Cardiac Magnetic Resonance Tissue Tracking. Scientific Reports, 10, Article No. 13126. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Hu, B.Y., Wang, J. and Yang, Z.G. (2019) Cardiac Magnetic Resonance Feature Tracking for Quantifying Right Ventricular Deformation in Type 2 Diabetes Mellitus Patients. Scien-tific Reports, 9, Article No. 11148. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
何健, 赵世华, 陆敏杰. 心脏磁共振特征追踪技术及其研究进展[J]. 磁共振成像, 2020, 11(6): 469-473.
|
|
[20]
|
万俊义, 赵世华. 心脏磁共振钆对比剂延迟强化的临床意义及判断预后的价值[J]. 中国医学影像技术, 2012, 28(8): 1600-1603.
|
|
[21]
|
Kwong, R.Y., et al. (2008) Incidence and Prognostic Implication of Unrecognized Myocardial Scar Characterized by Cardiac Magnetic Resonance in Diabetic Pa-tients without Clinical Evidence of Myocardial Infarction. Circulation, 118, 1011-1020. [Google Scholar] [CrossRef]
|
|
[22]
|
Tahir, E., Starekova, J., Muellerleile, K., von Stritzky, A., Munch, J., Avanesov, M., et al. (2018) Myocardial Fibrosis in Competitive Triathletes Detected by Con-trast-Enhanced CMR Correlates with Exercise-Induced Hypertension and Competition History. JACC: Cardiovascular Imaging, 11, 1260-1270. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Bojer, A.S., Sørensen, M.H., Vejlstrup, N., Goetze, J.P., Gæde, P. and Madsen, P.L. (2020) Distinct Non-Ischemic Myocardial Late Gadolinium Enhancement Lesions in Patients with Type 2 Diabetes. Cardiovascular Diabetology, 19, 184. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Storz, C., Hetterich, H., Lorbeer, R., Heber, S.D., Schafnitzel, A., Patscheider, H., et al. (2018) Myocardial Tissue Characterization by Contrast-Enhanced Cardiac Magnetic Resonance Imaging in Subjects with Prediabetes, Diabetes, and Normal Controls with Preserved Ejection Fraction from the General Population. European Heart Journal—Cardiovascular Imaging, 19, 701-708. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
陆敏杰, 赵世华. 我国心血管磁共振成像三十年发展历程[J]. 磁共振成像, 2019, 10(10): 727-731.
|
|
[26]
|
Bull, S., White, S.K., Piechnik, S.K., et al. (2013) Human Non-Contrast T1 Values and Correlation with Histology in Diffuse Fibrosis. Heart, 99, 932-937. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Puntmann, V.O., Voigt, T., Chen, Z., et al. (2013) Native T1 Mapping in Differentiation of Normal Myocardium from Diffuse Disease in Hypertrophic and Dilated Cardiomyopathy. JACC: Cardiovascular Imaging, 6, 475-484. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Paul, D., Su, R., Romain, M., et al. (2017) Feature Selection for Outcome Prediction in Oesophageal Cancer Using Genetic Algorithm and Random Forest Classifier. Computerized Medical Imaging and Graphics, 60, 42-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Kellman, P. and Hansen, M.S. (2014) T1-Mapping in the Heart: Accuracy and Precision. Journal of Cardiovascular Magnetic Resonance, 16, Article No. 2. [Google Scholar] [CrossRef]
|
|
[30]
|
Tadic, M., Cuspidi, C., Calicchio, F., et al. (2020) Diabetic Cardio-myopathy: How Can Cardiac Magnetic Resonance Help. Acta Diabetologica, 57, 1027-1034. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Cao, Y., Zeng, W., Cui, Y., Kong, X., Wang, M., Yu, J., Zhang, S., Song, J., Yan, X., Greiser, A., et al. (2018) Increased Myocardial Extracellular Volume Assessed by Cardiovascular Magnetic Resonance T1 Mapping and Its Determinants in Type 2 Diabetes Mellitus Patients with Normal Myocardial Systolic Strain. Cardiovascular Diabetology, 17, 7. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Khan, M.A., Yang, E.Y., Nguyen, D.T., et al. (2020) Examining the Relationship and Prognostic Implication of Diabetic Status and Extracellular Matrix Expansion by Cardiac Magnetic Resonance. Circulation: Cardiovascular Imaging, 13, e011000.
|
|
[33]
|
Cheng, A.S., Pegg, T.J., Karamitsos, T.D., Searle, N., Jerosch-Herold, M., Choudhury, R.P., et al. (2007) Cardiovascular Magnetic Resonance Perfusion Imaging at 3-Tesla for the Detection of Coronary Artery Disease: A Comparison with 1.5 Tesla. JACC: Journal of the American College of Cardiology, 49, 2440-2449. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Jerosch-Herold, M. (2010) Quantification of Myocardial Perfusion by Cardiovascular Magnetic Resonance. Journal of Cardiovascular Magnetic Resonance, 12, Article No. 57. [Google Scholar] [CrossRef]
|
|
[35]
|
Liu, X., Yang, Z.G., Gao, Y., et al. (2018) Left Ventricular Sub-clinical Myocardial Dysfunction in Uncomplicated Type 2 Diabetes Mellitus Is Associated with Impaired Myocardial Perfusion: A Contrast-Enhanced Cardiovascular Magnetic Resonance Study. Cardiovascular Diabetology, 17, Article No. 139. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Murthy, V.L., Naya, M. and Foster, C.R. (2011) Improved Car-diac Risk Assessment with Noninvasive Measures of Coronary Flow Reserve. Circulation, 124, 2215-2224. [Google Scholar] [CrossRef]
|